These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 14620183)
1. Intravenous immunoglobulins in rhesus hemolytic disease. Mukhopadhyay K; Murki S; Narang A; Dutta S Indian J Pediatr; 2003 Sep; 70(9):697-9. PubMed ID: 14620183 [TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Nasseri F; Mamouri GA; Babaei H Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357 [TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442 [TBL] [Abstract][Full Text] [Related]
4. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial. Elalfy MS; Elbarbary NS; Abaza HW Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607 [TBL] [Abstract][Full Text] [Related]
5. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease. Voto LS; Sexer H; Ferreiro G; Tavosnanska J; Orti J; Mathet ER; Margulies M; Margulies M J Perinat Med; 1995; 23(6):443-51. PubMed ID: 8904473 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial. Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn. Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn--a randomized controlled trial. Girish G; Chawla D; Agarwal R; Paul VK; Deorari AK Indian Pediatr; 2008 Aug; 45(8):653-9. PubMed ID: 18723908 [TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin in the management of hemolytic disease of the newborn. Mundy CA Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181 [TBL] [Abstract][Full Text] [Related]
12. Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis? Hammerman C; Vreman HJ; Kaplan M; Stevenson DK Acta Paediatr; 1996 Nov; 85(11):1351-3. PubMed ID: 8955465 [TBL] [Abstract][Full Text] [Related]
13. Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates. Demirel G; Akar M; Celik IH; Erdeve O; Uras N; Oguz SS; Dilmen U Int J Hematol; 2011 Jun; 93(6):700-703. PubMed ID: 21617887 [TBL] [Abstract][Full Text] [Related]
14. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646 [TBL] [Abstract][Full Text] [Related]
15. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease. Aylin T; Berkan G Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869 [No Abstract] [Full Text] [Related]
18. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn. Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448 [TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time. Vardar G; Okan MA; Karadag N; Topcuoglu S; Ozalkaya E; Karatepe HO; Karatekin G Niger J Clin Pract; 2022 Aug; 25(8):1262-1268. PubMed ID: 35975373 [TBL] [Abstract][Full Text] [Related]
20. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. Dağoğlu T; Ovali F; Samanci N; Bengisu E J Int Med Res; 1995; 23(4):264-71. PubMed ID: 7589769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]